acCELLapy is a healthcare services company formed with the mission to accelerate optimal delivery of Cell Therapy treatments to patients in need through partnerships with cancer providers and biotechnology companies.

Cell therapy is a rapidly advancing treatment modality in cancer care, set to save thousands of patient lives and reduce the burden of cancer treatment for countless others. With new therapies continuing to achieve compelling results, the eligible patient population is quickly expanding.

However, access to Cell Therapy is severely limited, with less than 15% of eligible patients receiving the treatment in 2020. Cell Therapy treatment is heavily concentrated in Academic Medical Centers, despite over 90% cancer patients being treated in the community. Unless there is significant investment in community-centered cell therapy services, the gap between the number of patients that could benefit from Cell Therapy and those receiving it will widen.

While Cell Therapy is complex, with the appropriate guidance, training and support, community oncology programs can offer safe, high quality Cell Therapy treatment to their patients. This is where acCELLapy comes in. acCELLapy was formed to expand access to Cell Therapy by partnering with providers and biotechs. With an experienced team of clinical and administrative experts, acCELLapy provides turn-key operational readiness education and training and co-managed services to support community cancer providers safely launch and expand Cell Therapy programs. For more information on our services, click here.